Eric Fossel

Eric Fossel has a long and distinguished career in the scientific and medical fields. Since 1970, they have been an Associate Professor at Harvard University. In 1994, they became the CEO of Strategic Science & Technologies LLC. In 2017, they became the Founder & CEO of BullseyeTx LLC, which was later acquired by Novilla Pharmaceuticals. Eric also held the role of Chief Scientific Officer at Novilla Pharmaceuticals and CEO at Odin Therapeutics in 2017.

Eric Fossel completed their Bachelor of Arts in Chemistry from Yale University in 1966. Eric then went on to earn a Master of Science in Chemistry from Yale University in 1967. After this, they obtained a Master of Philosophy in Chemistry from Yale University in 1970. Eric then completed a Doctor of Philosophy in Chemistry from Harvard University in 2000. Finally, they earned a Master of Theological Studies from Harvard University.